Vacuolar-type H+-ATPases (V-ATPases) are macromolecular proton pumps that acidify intracellular cargos and deliver protons across the plasma membrane of a variety of specialized cells, including bone-resorbing osteoclasts. Extracellular acidification is crucial for osteoclastic bone resorption, a process that initiates the dissolution of mineralized bone matrix. While the importance of V-ATPases in osteoclastic resorptive function is well-defined, whether V-ATPases facilitate additional aspects of osteoclast function and/or formation remains largely obscure. Here we report that the V-ATPase accessory subunit Ac45 participates in both osteoclast formation and function. Using a siRNA-based approach, we show that targeted suppression of Ac45 impairs intracellular acidification and endocytosis, both are prerequisite for osteoclastic bone resorptive function in vitro. Interestingly, we find that knockdown of Ac45 also attenuates osteoclastogenesis owing to a reduced fusion capacity of osteoclastic precursor cells. Finally, in an effort to gain more detailed insights into the functional role of Ac45 in osteoclasts, we attempted to generate osteoclast-specific Ac45 conditional knockout mice using a Cathepsin K-Cre-LoxP system. Surprisingly, however, insertion of the neomycin cassette in the Ac45-FloxNeo mice resulted in marked disturbances in CNS development and ensuing embryonic lethality thus precluding functional assessment of Ac45 in osteoclasts and peripheral bone tissues. Based on these unexpected findings we propose that, in addition to its canonical function in V-ATPase-mediated acidification, Ac45 plays versatile roles during osteoclast formation and function.
References
[1]
Smith AN, Skaug J, Choate KA, Nayir A, Bakkaloglu A, et al. (2000) Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing. Nat Genet 26: 71–75.
[2]
Martinez-Zaguilan R, Lynch RM, Martinez GM, Gillies RJ (1993) Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells. Am J Physiol 265: C1015–1029.
[3]
Li YP, Chen W, Liang Y, Li E, Stashenko P (1999) Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat Genet 23: 447–451.
[4]
Frattini A, Orchard PJ, Sobacchi C, Giliani S, Abinun M, et al. (2000) Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. 25: 343–346.
[5]
Forgac M (2007) Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol 8: 917–929.
[6]
Toei M, Saum R, Forgac M (2010) Regulation and isoform function of the V-ATPases. Biochemistry 49: 4715–4723.
[7]
Forgac M (2000) Structure, mechanism and regulation of the clathrin-coated vesicle and yeast vacuolar H(+)-ATPases. J Exp Biol 203: 71–80.
[8]
Stevens TH, Forgac M (1997) Structure, function and regulation of the vacuolar (H+)-ATPase. Annu Rev Cell Dev Biol 13: 779–808.
[9]
Hu Y, Nyman J, Muhonen P, Vaananen HK, Laitala-Leinonen T (2005) Inhibition of the osteoclast V-ATPase by small interfering RNAs. FEBS Lett 579: 4937–4942.
[10]
Feng H, Cheng T, Pavlos NJ, Yip KH, Carrello A, et al. (2008) Cytoplasmic terminus of vacuolar type proton pump accessory subunit Ac45 is required for proper interaction with V(0) domain subunits and efficient osteoclastic bone resorption. J Biol Chem 283: 13194–13204.
[11]
Laitala T, Vaananen HK (1994) Inhibition of bone resorption in vitro by antisense RNA and DNA molecules targeted against carbonic anhydrase II or two subunits of vacuolar H(+)-ATPase. J Clin Invest 93: 2311–2318.
[12]
Laitala-Leinonen T, Lowik C, Papapoulos S, Vaananen HK (1999) Inhibition of intravacuolar acidification by antisense RNA decreases osteoclast differentiation and bone resorption in vitro. J Cell Sci 112(Pt 21): 3657–3666.
[13]
Lee SH, Rho J, Jeong D, Sul JY, Kim T, et al. (2006) v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med 12: 1403–1409.
[14]
Scimeca JC, Quincey D, Parrinello H, Romatet D, Grosgeorge J, et al. (2003) Novel mutations in the TCIRG1 gene encoding the a3 subunit of the vacuolar proton pump in patients affected by infantile malignant osteopetrosis. Hum Mutat 21: 151–157.
[15]
Sobacchi C, Frattini A, Orchard P, Porras O, Tezcan I, et al. (2001) The mutational spectrum of human malignant autosomal recessive osteopetrosis. Hum Mol Genet 10: 1767–1773.
[16]
Sundquist K, Lakkakorpi P, Wallmark B, Vaananen K (1990) Inhibition of osteoclast proton transport by bafilomycin A1 abolishes bone resorption. Biochem Biophys Res Commun 168: 309–313.
[17]
Sundquist KT, Marks SC (1994) Bafilomycin A1 inhibits bone resorption and tooth eruption in vivo. J Bone Miner Res 9: 1575–1582.
[18]
Taranta A, Migliaccio S, Recchia I, Caniglia M, Luciani M, et al. (2003) Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis. Am J Pathol 162: 57–68.
[19]
Visentin L, Dodds RA, Valente M, Misiano P, Bradbeer JN, et al. (2000) A selective inhibitor of the osteoclastic V-H(+)-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats. J Clin Invest 106: 309–318.
[20]
Wu H, Xu G, Li YP (2009) Atp6v0d2 is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption. J Bone Miner Res 24: 871–885.
[21]
Feng H, Cheng T, Steer JH, Joyce DA, Pavlos NJ, et al. (2009) Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis. J Biol Chem 284: 14667–14676.
[22]
Supek F, Supekova L, Mandiyan S, Pan YC, Nelson H, et al. (1994) A novel accessory subunit for vacuolar H(+)-ATPase from chromaffin granules. J Biol Chem 269: 24102–24106.
[23]
Getlawi F, Laslop A, Schagger H, Ludwig J, Haywood J, et al. (1996) Chromaffin granule membrane glycoprotein IV is identical with Ac45, a membrane-integral subunit of the granule's H(+)-ATPase. Neurosci Lett 219: 13–16.
[24]
Holthuis JC, Jansen EJ, Schoonderwoert VT, Burbach JP, Martens GJ (1999) Biosynthesis of the vacuolar H+-ATPase accessory subunit Ac45 in Xenopus pituitary. Eur J Biochem 262: 484–491.
[25]
Muench SP, Huss M, Song CF, Phillips C, Wieczorek H, et al. (2009) Cryo-electron microscopy of the vacuolar ATPase motor reveals its mechanical and regulatory complexity. J Mol Biol 386: 989–999.
[26]
Wilkens S, Forgac M (2001) Three-dimensional structure of the vacuolar ATPase proton channel by electron microscopy. J Biol Chem 276: 44064–44068.
Louagie E, Taylor NA, Flamez D, Roebroek AJ, Bright NA, et al. (2008) Role of furin in granular acidification in the endocrine pancreas: identification of the V-ATPase subunit Ac45 as a candidate substrate. Proc Natl Acad Sci U S A 105: 12319–12324.
[29]
Blair HC, Teitelbaum SL, Ghiselli R, Gluck S (1989) Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 245: 855–857.
[30]
Camacho M, Machado JD, Montesinos MS, Criado M, Borges R (2006) Intragranular pH rapidly modulates exocytosis in adrenal chromaffin cells. J Neurochem 96: 324–334.
[31]
Gluck S, Cannon C, Al-Awqati Q (1982) Exocytosis regulates urinary acidification in turtle bladder by rapid insertion of H+ pumps into the luminal membrane. Proc Natl Acad Sci U S A 79: 4327–4331.
[32]
Palmgren MG (1991) Acridine orange as a probe for measuring pH gradients across membranes: mechanism and limitations. Anal Biochem 192: 316–321.
[33]
Baron R (1989) Molecular mechanisms of bone resorption by the osteoclast. Anat Rec 224: 317–324.
[34]
Vaananen HK, Zhao H, Mulari M, Halleen JM (2000) The cell biology of osteoclast function. J Cell Sci 113(Pt 3): 377–381.
[35]
Bayer MJ, Reese C, Buhler S, Peters C, Mayer A (2003) Vacuole membrane fusion: V0 functions after trans-SNARE pairing and is coupled to the Ca2+-releasing channel. J Cell Biol 162: 211–222.
[36]
Ochotny N, Flenniken AM, Owen C, Voronov I, Zirngibl RA, et al. (2011) The V-ATPase a3 subunit mutation R740S is dominant negative and results in osteopetrosis in mice. J Bone Miner Res 26: 1484–1493.
[37]
Jansen EJ, Scheenen WJ, Hafmans TG, Martens GJ (2008) Accessory subunit Ac45 controls the V-ATPase in the regulated secretory pathway. Biochim Biophys Acta 1783: 2301–2310.
[38]
El Far O, Seagar M (2011) A role for V-ATPase subunits in synaptic vesicle fusion? J Neurochem 117: 603–612.
[39]
Peters C, Bayer MJ, Buhler S, Andersen JS, Mann M, et al. (2001) Trans-complex formation by proteolipid channels in the terminal phase of membrane fusion. Nature 409: 581–588.
[40]
Ishizuka H, Garcia-Palacios V, Lu G, Subler MA, Zhang H, et al. (2011) ADAM8 enhances osteoclast precursor fusion and osteoclast formation in vitro and in vivo. J Bone Miner Res 26: 169–181.
[41]
Schoonderwoert VT, Martens GJ (2002) Targeted disruption of the mouse gene encoding the V-ATPase accessory subunit Ac45. Mol Membr Biol 19: 67–71.
[42]
Crawford LW, Foley JF, Elmore SA (2010) Histology atlas of the developing mouse hepatobiliary system with emphasis on embryonic days 9.5-18.5. Toxicol Pathol 38: 872–906.
[43]
Ramirez MI, Pollack L, Millien G, Cao YX, Hinds A, et al. (2002) The alpha-isoform of caveolin-1 is a marker of vasculogenesis in early lung development. J Histochem Cytochem 50: 33–42.
[44]
Jansen EJ, Hafmans TG, Martens GJ (2010) V-ATPase-mediated granular acidification is regulated by the V-ATPase accessory subunit Ac45 in POMC-producing cells. Mol Biol Cell 21: 3330–3339.
[45]
Drose S, Altendorf K (1997) Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. J Exp Biol 200: 1–8.
[46]
Xu J, Feng HT, Wang C, Yip KH, Pavlos N, et al. (2003) Effects of Bafilomycin A1: an inhibitor of vacuolar H (+)-ATPases on endocytosis and apoptosis in RAW cells and RAW cell-derived osteoclasts. J Cell Biochem 88: 1256–1264.
[47]
Roodman GD (1999) Cell biology of the osteoclast. Exp Hematol 27: 1229–1241.
[48]
Nesbitt SA, Horton MA (1997) Trafficking of matrix collagens through bone-resorbing osteoclasts. Science 276: 266–269.
[49]
Salo J, Lehenkari P, Mulari M, Metsikko K, Vaananen HK (1997) Removal of osteoclast bone resorption products by transcytosis. Science 276: 270–273.
[50]
Feng S, Deng L, Chen W, Shao J, Xu G, et al. (2009) Atp6v1c1 is an essential component of the osteoclast proton pump and in F-actin ring formation in osteoclasts. Biochem J 417: 195–203.
[51]
Vitavska O, Merzendorfer H, Wieczorek H (2005) The V-ATPase subunit C binds to polymeric F-actin as well as to monomeric G-actin and induces cross-linking of actin filaments. J Biol Chem 280: 1070–1076.
[52]
Vitavska O, Wieczorek H, Merzendorfer H (2003) A novel role for subunit C in mediating binding of the H+-V-ATPase to the actin cytoskeleton. J Biol Chem 278: 18499–18505.
[53]
Yagi M, Miyamoto T, Sawatani Y, Iwamoto K, Hosogane N, et al. (2005) DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 202: 345–351.
[54]
Lewandoski M (2001) Conditional control of gene expression in the mouse. Nat Rev Genet 2: 743–755.
[55]
Meyers EN, Lewandoski M, Martin GR (1998) An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat Genet 18: 136–141.
[56]
Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K (1994) Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265: 103–106.
[57]
Xu J, Tan JW, Huang L, Gao XH, Laird R, et al. (2000) Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-kappaB ligand. J Bone Miner Res 15: 2178–2186.
[58]
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–408.
[59]
Pavlos NJ, Cheng TS, Qin A, Ng PY, Feng HT, et al. (2011) Tctex-1, a Novel Interaction Partner of Rab3d, Is Required for Osteoclastic Bone Resorption. Mol Cell Biol 31: 1551–1564.
